Sette C, Conti M
Division of Reproductive Biology, Department of Gynecology and Obstetrics, Stanford University Medical Center, Stanford, California 94305-5317, USA.
J Biol Chem. 1996 Jul 12;271(28):16526-34. doi: 10.1074/jbc.271.28.16526.
A cAMP-specific phosphodiesterase (PDE4D3) is activated in rat thyroid cells by TSH through a cAMP-dependent phosphorylation (Sette, C., Iona, S., and Conti, M.(1994) J. Biol. Chem. 269, 9245-9252). This short term activation may be involved in the termination of the hormonal stimulation and/or in the induction of desensitization. Here, we have further characterized the protein kinase A (PKA)-dependent phosphorylation of this PDE4D3 variant and identified the phosphorylation site involved in the PDE activation. The PKA-dependent incorporation of phosphate in the partially purified, recombinant rat PDE4D3 followed a time course similar to that of activation. Half-maximal activation of the enzyme was obtained with 0.6 microM ATP and 30 nM of the catalytic subunit of PKA. Phosphorylation altered the Vmax of the PDE without affecting the Km for cAMP. Phosphorylation also modified the Mg2+ requirements and the pattern of inhibition by rolipram. Cyanogen bromide cleavage of the 32P-labeled rat PDE4D3 yielded two or three major phosphopeptide bands, providing a first indication that the enzyme may be phosphorylated at multiple sites in a cell-free system. Site-directed mutagenesis was performed on the serine residues present at the amino terminus of this PDE in the context of preferred motifs for PKA phosphorylation. The PKA-dependent incorporation of 32P was reduced to the largest extent in mutants with both Ser13 --> Ala and Ser54 --> Ala substitutions, confirming the presence of more than one phosphorylation site in rat PDE4D3. While substitution of serine 13 with alanine did not affect the activation by PKA, substitution of Ser54 completely suppressed the kinase activation. Similar conclusions were reached with wild type and mutated PDE4D3 proteins expressed in MA-10 cells, where the endogenous PKA was activated by dibutyryl cAMP. Again, the PDE with the Ser54 --> Ala substitution could not be activated by the endogenous PKA in the intact cell. These findings support the hypothesis that the PDE4D3 variant contains a regulatory domain target for phosphorylation at the amino terminus of the protein and that Ser54 in this domain plays a crucial role in activation.
一种环磷酸腺苷特异性磷酸二酯酶(PDE4D3)在大鼠甲状腺细胞中可被促甲状腺激素(TSH)通过环磷酸腺苷依赖性磷酸化作用激活(塞特,C.,约纳,S.,以及孔蒂,M.(1994年)《生物化学杂志》269卷,9245 - 9252页)。这种短期激活可能参与激素刺激的终止和/或脱敏诱导过程。在此,我们进一步对该PDE4D3变体的蛋白激酶A(PKA)依赖性磷酸化进行了表征,并确定了参与磷酸二酯酶激活的磷酸化位点。在部分纯化的重组大鼠PDE4D3中,PKA依赖性的磷酸盐掺入时间进程与激活过程相似。用0.6微摩尔/升的ATP和30纳摩尔的PKA催化亚基可使该酶达到半数最大激活。磷酸化改变了磷酸二酯酶的最大反应速度(Vmax),而不影响其对环磷酸腺苷的米氏常数(Km)。磷酸化还改变了对镁离子的需求以及罗匹尼罗的抑制模式。对经32P标记的大鼠PDE4D3进行溴化氰裂解产生了两条或三条主要的磷酸肽带,这初步表明该酶在无细胞系统中可能在多个位点被磷酸化。在该PDE氨基末端存在的丝氨酸残基上,针对PKA磷酸化的优先基序进行了定点诱变。在丝氨酸13突变为丙氨酸以及丝氨酸54突变为丙氨酸的双突变体中,PKA依赖性的32P掺入减少幅度最大,这证实了大鼠PDE4D3中存在多个磷酸化位点。虽然将丝氨酸13替换为丙氨酸不影响PKA的激活,但将丝氨酸54替换则完全抑制了激酶激活。在MA - 10细胞中表达的野生型和突变型PDE4D3蛋白也得出了类似结论,在MA - 10细胞中,内源性PKA被二丁酰环磷酸腺苷激活。同样,丝氨酸54突变为丙氨酸的磷酸二酯酶在完整细胞中不能被内源性PKA激活。这些发现支持了这样一种假说,即PDE4D3变体在蛋白质的氨基末端含有一个用于磷酸化的调节结构域靶点,并且该结构域中的丝氨酸54在激活过程中起关键作用。